← Open Payments lookup

RUPINDER BRAR: Open Payments

NPI 1548903404 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,802 in 77 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,802

Food & beverage: $1,802
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$443
E.R. Squibb & Sons, L.L.C.15$270
Vanda Pharmaceuticals Inc.10$253
ABBVIE INC.15$222
Alkermes, Inc.7$196
Otsuka America Pharmaceutical, Inc.8$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$103
Neurocrine BioSciences, Inc.4$66
Luye Pharma (USA) Ltd.2$44
Janssen Pharmaceuticals, Inc1$21

Products named: AUSTEDO XR, COBENFY, VRAYLAR, FANAPT, LYBALVI, CAPLYTA, ABILIFY MAINTENA, HETLIOZ.

Industry payments across OH — which companies pay providers there.